- 全部删除
您的购物车当前为空
HSD17B13-IN-4 (Compound 95) 是一种有力的羟基类固醇 17β-脱氢酶 13 (HSD17B13) 抑制剂,对雌二醇底物的 LCMS Ki值为 ≤ 50 nM。它适用于研究与肝病、代谢性疾病或心血管疾病相关的状况,如非酒精性脂肪肝病 (NAFLD)、非酒精性脂肪性肝炎 (NASH) 或药物性肝损伤 (DILI)。
HSD17B13-IN-4 (Compound 95) 是一种有力的羟基类固醇 17β-脱氢酶 13 (HSD17B13) 抑制剂,对雌二醇底物的 LCMS Ki值为 ≤ 50 nM。它适用于研究与肝病、代谢性疾病或心血管疾病相关的状况,如非酒精性脂肪肝病 (NAFLD)、非酒精性脂肪性肝炎 (NASH) 或药物性肝损伤 (DILI)。

HSD17B13-IN-4 相关产品
| 产品描述 | HSD17B13-IN-4 (Compound 95) is an inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13) with a Ki value for the substrate estradiol LCMS of ≤ 50 nM. It can be utilized in research on liver diseases, metabolic disorders, or cardiovascular diseases such as NAFLD, NASH, or drug-induced liver injury (DILI). |
| 分子式 | C26H15Cl2F3N4O3S |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容